Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres

Background: Immune checkpoint inhibitors (ICIs) have revolutionized the therapeutic horizons of various cancers. However, immune-related adverse events have been reported, including interstitial lung diseases. Our aim was to describe the clinical and radiological features and survival of a multicent...

Descripción completa

Detalles Bibliográficos
Autores principales: Cameli, Paolo, Faverio, Paola, Ferrari, Katia, Bonti, Viola, Marsili, Stefania, Mazzei, Maria Antonietta, Mazzoni, Francesca, Bartolucci, Maurizio, Scotti, Vieri, Bertolini, Federica, Barbieri, Fausto, Baldessari, Cinzia, Veronese, Chiara, Boffi, Roberto, Brighenti, Matteo, Cortinovis, Diego, Dominici, Massimo, Pesci, Alberto, Bargagli, Elena, Luppi, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410477/
https://www.ncbi.nlm.nih.gov/pubmed/36013328
http://dx.doi.org/10.3390/life12081149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410477/
https://www.ncbi.nlm.nih.gov/pubmed/36013328
http://dx.doi.org/10.3390/life12081149

Ejemplares similares